2021 ICD-10-CM Code H10.823

Rosacea conjunctivitis, bilateral

Version 2021

Valid for Submission

H10.823 is a billable diagnosis code used to specify a medical diagnosis of rosacea conjunctivitis, bilateral. The code H10.823 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.

ICD-10:H10.823
Short Description:Rosacea conjunctivitis, bilateral
Long Description:Rosacea conjunctivitis, bilateral

Code Classification

Replacement Code

H10823 replaces the following previously assigned ICD-10 code(s):

Information for Patients


Pinkeye

Also called: Conjunctivitis

Conjunctivitis is the medical name for pink eye. It involves inflammation of the outer layer of the eye and inside of the eyelid. It can cause swelling, itching, burning, discharge, and redness. Causes include

Pinkeye usually does not affect vision. Infectious pink eye can easily spread from one person to another. The infection will clear in most cases without medical care, but bacterial pinkeye needs treatment with antibiotic eye drops or ointment.

NIH: National Eye Institute


[Learn More in MedlinePlus]

Rosacea

Also called: Acne rosacea

Rosacea is a long-term disease that affects your skin and sometimes your eyes. It causes redness and pimples. Rosacea is most common in women and people with fair skin. It most often affects middle-aged and older adults.

In most cases, rosacea only affects the face. Symptoms can include

No one knows what causes rosacea. You may be more likely to have it if you blush a lot or if rosacea runs in your family. Rosacea is not dangerous. There is no cure, but treatments can help. They include medicines and sometimes surgery.

NIH: National Institute of Arthritis and Musculoskeletal and Skin Diseases


[Learn More in MedlinePlus]

Code History

  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019